Provided by Tiger Trade Technology Pte. Ltd.

BAO PHARMA-B

15.820
-0.190-1.19%
Volume:205.80K
Turnover:3.32M
Market Cap:5.13B
PE:-11.63
High:16.290
Open:15.800
Low:15.800
Close:16.010
52wk High:206.000
52wk Low:15.300
Shares:324.00M
HK Float Shares:153.00M
Volume Ratio:0.93
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.360
ROE:-31.30%
ROA:-10.95%
PB:3.04
PE(LYR):-11.63
PS:258.22

Loading ...

Insider Purchases Worth CN¥5.34m See Losses As Shanghai Bao Pharmaceuticals Market Value Drops To HK$5.6b

Simply Wall St.
·
Jul 18

BAO PHARMA-B Repurchases Shares for HK$1.99 Million on July 17

Stock News
·
Jul 17

Shanghai Bao Pharmaceuticals Files HKEX Next-day Return Disclosing Share Buyback at HKD 17.71 Each

Reuters
·
Jul 17

Bao Pharma Repurchases 100,300 H-Shares for HKD 1.99 Million, Lifting Treasury Stock to 1.04 Million Shares

Bulletin Express
·
Jul 15

Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure Return on Share Repurchase at HKD 19.88 Average Price

Reuters
·
Jul 15

BAO PHARMA-B repurchases 101,700 H-shares for HK$1.99 million; treasury stock rises to 834,900 shares

Bulletin Express
·
Jul 13

Shanghai Bao Pharmaceuticals Files HKEX Disclosure Return on Share Repurchase

Reuters
·
Jul 13

BAO PHARMA-B Repurchases 149,800 Shares for HK$2.99 Million on July 10

Stock News
·
Jul 10

Bao Pharma Executes HKD 3.00 Million Share Buyback, Bringing Treasury Shares to 0.38% of Mandate Capacity

Bulletin Express
·
Jul 09

Shanghai Bao Pharma Files HKEX Return Disclosing Share Buyback at HKD 19.53 Per Share

Reuters
·
Jul 09

BAO PHARMA-B Surges Over 6% in Session as World's First Synthetic Biology Recombinant Ulinastatin BJ044 Gains Clinical Trial Approval

Deep News
·
Jul 09

BAO PHARMA-B Cuts Free Float by 0.09% Through HKD 2.84 Million Share Buyback

Bulletin Express
·
Jul 08

BAO PHARMA-B Repurchases Shares Worth HK$2.84 Million on July 8

Stock News
·
Jul 08

Bao Pharma appoints new joint company secretary and secures Listing Rules waiver

Bulletin Express
·
Jul 08

BAOJI Pharmaceuticals-B Announces Appointment of Tsang Chun Ho as Joint Company Secretary

Stock News
·
Jul 08

Shanghai Bao Pharma Appoints Tsang Chun Ho as Joint Company Secretary, Authorized Representative and Process Agent

Reuters
·
Jul 08

Bao Pharma repurchases 137,300 H-shares, treasury stock climbs to 284,600

Bulletin Express
·
Jul 07

BAO PHARMA-B Repurchases 52,100 Shares for Approximately HK$971,400 on July 6

Stock News
·
Jul 06

Bao Pharma Buys Back 52,100 H-Shares, Treasury Stock Rises to 147,300 Shares

Bulletin Express
·
Jul 06

Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure After Share Buyback at HKD 18.65

Reuters
·
Jul 06